163 related articles for article (PubMed ID: 12467302)
1. NFkappaB-dependent chemoresistance in solid tumors.
Arlt A; Schäfer H
Int J Clin Pharmacol Ther; 2002 Aug; 40(8):336-47. PubMed ID: 12467302
[TBL] [Abstract][Full Text] [Related]
2. The role of NF-kappaB/IkappaB proteins in cancer: implications for novel treatment strategies.
Schwartz SA; Hernandez A; Mark Evers B
Surg Oncol; 1999 Nov; 8(3):143-53. PubMed ID: 11113665
[TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
4. Constitutive activation of transcription factor NFkappaB as a possible marker of sensitivity of neoplastic cells to anthracyclines.
Gruber BM; Anuszewska EL; Bubko I; Kasprzycka-Guttman T; Misiewicz I; Skupińska K; Priebe W; Fokt I
Acta Pol Pharm; 2005; 62(1):17-23. PubMed ID: 16022489
[TBL] [Abstract][Full Text] [Related]
5. TAK-ing aim at chemoresistance: The emerging role of MAP3K7 as a target for cancer therapy.
Santoro R; Carbone C; Piro G; Chiao PJ; Melisi D
Drug Resist Updat; 2017 Nov; 33-35():36-42. PubMed ID: 29145973
[TBL] [Abstract][Full Text] [Related]
6. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors.
Dhandapani KM; Mahesh VB; Brann DW
J Neurochem; 2007 Jul; 102(2):522-38. PubMed ID: 17596214
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of Twist-1 by NF-kappaB blocks cytotoxicity induced by chemotherapeutic drugs.
Pham CG; Bubici C; Zazzeroni F; Knabb JR; Papa S; Kuntzen C; Franzoso G
Mol Cell Biol; 2007 Jun; 27(11):3920-35. PubMed ID: 17403902
[TBL] [Abstract][Full Text] [Related]
8. IkappaBalpha gene therapy in tumor necrosis factor-alpha- and chemotherapy-mediated apoptosis of hepatocellular carcinomas.
Tietze MK; Wuestefeld T; Paul Y; Zender L; Trautwein C; Manns MP; Kubicka S
Cancer Gene Ther; 2000 Oct; 7(10):1315-23. PubMed ID: 11059688
[TBL] [Abstract][Full Text] [Related]
9. NFκB-Associated Pathways in Progression of Chemoresistance to 5-Fluorouracil in an In Vitro Model of Colonic Carcinoma.
Körber MI; Staribacher A; Ratzenböck I; Steger G; Mader RM
Anticancer Res; 2016 Apr; 36(4):1631-9. PubMed ID: 27069140
[TBL] [Abstract][Full Text] [Related]
10. Targeting the NFκB signaling pathways for breast cancer prevention and therapy.
Wang W; Nag SA; Zhang R
Curr Med Chem; 2015; 22(2):264-89. PubMed ID: 25386819
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Targeting of Cell Cycle, Apoptotic and Cell Adhesion Signaling Pathways Implicated in Chemoresistance of Cancer Cells.
Alimbetov D; Askarova S; Umbayev B; Davis T; Kipling D
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882812
[TBL] [Abstract][Full Text] [Related]
12. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
13. Failure of apoptosis and activation on NFkappaB by celecoxib and aspirin in lung cancer cell lines.
Gradilone A; Silvestri I; Scarpa S; Morrone S; Gandini O; Pulcinelli FM; Gianni W; Frati L; Aglianò AM; Gazzaniga P
Oncol Rep; 2007 Apr; 17(4):823-8. PubMed ID: 17342322
[TBL] [Abstract][Full Text] [Related]
14. Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells.
Shimada K; Nakamura M; Ishida E; Kishi M; Yonehara S; Konishi N
Mol Carcinog; 2002 Nov; 35(3):127-37. PubMed ID: 12410564
[TBL] [Abstract][Full Text] [Related]
15. Cell cycle regulation and apoptotic cell death in experimental colon carcinogenesis: intervening with cyclooxygenase-2 inhibitors.
Saini MK; Sanyal SN
Nutr Cancer; 2015; 67(4):620-36. PubMed ID: 25825916
[TBL] [Abstract][Full Text] [Related]
16. [Specificity and selectivity of the NFkappaB response].
Czyz M
Postepy Biochem; 2005; 51(1):60-8. PubMed ID: 16209343
[TBL] [Abstract][Full Text] [Related]
17. NF-κB in pancreatic cancer: Its key role in chemoresistance.
Li Q; Yang G; Feng M; Zheng S; Cao Z; Qiu J; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2018 May; 421():127-134. PubMed ID: 29432846
[TBL] [Abstract][Full Text] [Related]
18. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance.
Singh RP; Mallikarjuna GU; Sharma G; Dhanalakshmi S; Tyagi AK; Chan DC; Agarwal C; Agarwal R
Clin Cancer Res; 2004 Dec; 10(24):8641-7. PubMed ID: 15623648
[TBL] [Abstract][Full Text] [Related]
19. FSTL1 Promotes Metastasis and Chemoresistance in Esophageal Squamous Cell Carcinoma through NFκB-BMP Signaling Cross-talk.
Lau MC; Ng KY; Wong TL; Tong M; Lee TK; Ming XY; Law S; Lee NP; Cheung AL; Qin YR; Chan KW; Ning W; Guan XY; Ma S
Cancer Res; 2017 Nov; 77(21):5886-5899. PubMed ID: 28883005
[TBL] [Abstract][Full Text] [Related]
20. Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy.
Li F; Sethi G
Biochim Biophys Acta; 2010 Apr; 1805(2):167-80. PubMed ID: 20079806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
